• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Perrigo Completes Acquisition Of Ranir, Raises Guidance

Share:

July 8, 2019

Perrigo Company plc (NYSE; TASE: PRGO) today announced the successful completion of its acquisition of Ranir Global Holdings LLC (“Ranir”), the leading global store brand supplier of oral self-care products, for $750 million in cash. This transaction advances Perrigo’s transformation to a consumer-focused, self-care company while enhancing its position as a global leader in consumer self-care solutions.

Perrigo CEO and President Murray S. Kessler commented, “We are pleased to announce the successful completion of this bolt-on acquisition and look forward to welcoming the talented Ranir team to the Perrigo family. Our combined scale, global presence, innovation pipelines, and shared self-care strategies immediately accelerates growth and enhances our robust store brand portfolio. We look forward to providing customers and consumers with our expanded product offerings in this adjacent self-care category.”

Kessler continued, “As stated at our investor conference, the successful closing of the Ranir acquisition represented upside to our 2019 guidance. Based on today’s closing we are adjusting our 2019 adjusted diluted EPS guidance range up by 10 cents.”

Date: July 08, 2019

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Perrigo

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • TCR-Focused Immatics to Merge with Arya SciencesTCR-Focused Immatics to Merge with Arya Sciences
  • Trovagene Announces $5.0 Million Private Placement Priced At-the-MarketTrovagene Announces $5.0 Million Private Placement Priced At-the-Market
  • Impact Of Covid-19 On Dihydrotanshinone Market 2020-2026Impact Of Covid-19 On Dihydrotanshinone Market 2020-2026
  • Why COVID-19 is Prompting Device OEMs to Partner with Software DevelopersWhy COVID-19 is Prompting Device OEMs to Partner with Software Developers
  • Philips, Spencer Health Launches In-Home Medication Adherence & Telehealth Platform in EuropePhilips, Spencer Health Launches In-Home Medication Adherence & Telehealth Platform in Europe
  • Major Fitness Brands Now Offering Workout Incentives Through Apple WatchesMajor Fitness Brands Now Offering Workout Incentives Through Apple Watches
  • UpHealth Sells Cloudbreak Health Business to GTCR for $180MUpHealth Sells Cloudbreak Health Business to GTCR for $180M
  • Sales of Bioprocess Technology Set to Expand By 5x as Application in Biopharmaceutical Industry Rises: Future Market InsightsSales of Bioprocess Technology Set to Expand By 5x as Application in Biopharmaceutical Industry Rises: Future Market Insights

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications